Concepts (55)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, CCR7 | 3 | 2024 | 17 | 1.110 |
Why?
|
| Chemokines, CC | 1 | 2022 | 53 | 0.720 |
Why?
|
| Type C Phospholipases | 1 | 2020 | 24 | 0.640 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 1679 | 0.330 |
Why?
|
| Chemotaxis | 2 | 2024 | 66 | 0.240 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 9 | 0.220 |
Why?
|
| Hepadnaviridae | 1 | 2004 | 1 | 0.220 |
Why?
|
| Chemokine CCL19 | 1 | 2024 | 8 | 0.220 |
Why?
|
| Virus Integration | 1 | 2004 | 65 | 0.210 |
Why?
|
| DNA, Viral | 1 | 2004 | 323 | 0.190 |
Why?
|
| Lymph Nodes | 1 | 2022 | 73 | 0.180 |
Why?
|
| Cell Physiological Phenomena | 1 | 2020 | 9 | 0.160 |
Why?
|
| Biological Products | 1 | 2021 | 91 | 0.160 |
Why?
|
| Antiviral Agents | 1 | 2021 | 189 | 0.160 |
Why?
|
| Lead Poisoning, Nervous System, Childhood | 1 | 2019 | 9 | 0.160 |
Why?
|
| Isoenzymes | 1 | 2020 | 169 | 0.150 |
Why?
|
| Organometallic Compounds | 1 | 2019 | 72 | 0.150 |
Why?
|
| Microglia | 1 | 2019 | 204 | 0.130 |
Why?
|
| Hippocampus | 1 | 2019 | 591 | 0.120 |
Why?
|
| Humans | 4 | 2024 | 42163 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 2598 | 0.070 |
Why?
|
| Animals | 5 | 2024 | 16695 | 0.060 |
Why?
|
| Chemokine CCL21 | 1 | 2024 | 14 | 0.060 |
Why?
|
| Female | 2 | 2022 | 24018 | 0.050 |
Why?
|
| Base Pair Mismatch | 1 | 2004 | 15 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 65 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2004 | 148 | 0.050 |
Why?
|
| DNA Primers | 1 | 2004 | 295 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2004 | 118 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2004 | 207 | 0.050 |
Why?
|
| Plasmids | 1 | 2004 | 247 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2024 | 150 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2024 | 284 | 0.050 |
Why?
|
| Chickens | 1 | 2004 | 148 | 0.050 |
Why?
|
| Transfection | 1 | 2004 | 526 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 454 | 0.050 |
Why?
|
| DNA Repair | 1 | 2004 | 196 | 0.050 |
Why?
|
| Base Sequence | 1 | 2004 | 997 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2004 | 158 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 211 | 0.050 |
Why?
|
| Immunity | 1 | 2021 | 60 | 0.040 |
Why?
|
| Cell Movement | 1 | 2024 | 640 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 249 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2019 | 31 | 0.040 |
Why?
|
| Lactation | 1 | 2019 | 44 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2019 | 350 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2019 | 452 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2021 | 1586 | 0.030 |
Why?
|
| Macrophages | 1 | 2019 | 515 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 1848 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 1804 | 0.030 |
Why?
|
| Mice | 1 | 2024 | 6490 | 0.030 |
Why?
|
| CHO Cells | 1 | 2004 | 123 | 0.010 |
Why?
|
| Cricetinae | 1 | 2004 | 241 | 0.010 |
Why?
|
| Male | 1 | 2019 | 22779 | 0.010 |
Why?
|